ATAI Strategic Vote Results (Form 8-K)

ATAI Life Sciences N.V. shareholders overwhelmingly approved critical corporate actions at the November 4, 2025, EGM.

• Key Transaction Approvals: Shareholders ratified the proposed acquisition of Beckley Psytech Limited (Proposal 1) and the associated Share Issuance (Proposal 2).
• Redomiliciation Confirmed: Proposals related to the merger with LuxCo to effectuate the redomiciliation into a Delaware corporation (Proposals 4, 5, 6, 7) were approved.
• Board Appointments: Cosmo Feilding-Mellen and Dr. Robert Hershberg were